| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Immunovant, Inc. | IMVT | Grant | Common Stock, $0.0001 par value per share | 4.5M | $38.00 | $170M | | 10/02/2023 |
| 10/02/2023 | Immunovant, Inc. | IMVT | Purchase | Common Stock, $0.0001 par value per share | 1.5M | $38.00 | $58M | | 10/02/2023 |
| 10/06/2022 | Immunovant, Inc. | IMVT | Purchase | Common Stock, $0.0001 par value per share | 416.7k | $6.00 | $2.5M | | 10/06/2022 |
| 10/18/2021 | Arbutus Biopharma Corp | ABUS | Conversion | Common shares, without par value | 22.8M | $0.00 | $0 | | 10/18/2021 |
| 10/18/2021 | Arbutus Biopharma Corp | ABUS | Conversion | Series A participating convertible preferred shares | 1.2M | $7.13 | $8.3M | | 10/18/2021 |
| 08/02/2021 | Immunovant, Inc. | IMVT | Other (acquisition) | Common Stock, $0.0001 par value per share | 17M | $0.00 | $0 | | 08/02/2021 |
| 09/17/2020 | Immunovant, Inc. | IMVT | Other (acquisition) | Common Stock, $0.0001 par value per share | 8.8M | $0.00 | $0 | | 09/17/2020 |
| 09/04/2020 | Immunovant, Inc. | IMVT | Purchase | Common Stock, $0.0001 par value per share | 380k | $33.00 | $12.5M | | 09/04/2020 |
| 05/12/2020 | Immunovant, Inc. | IMVT | Other (acquisition) | Common Stock, $0.0001 par value per share | 8.8M | $0.00 | $0 | | 05/12/2020 |
| 04/16/2020 | Immunovant, Inc. | IMVT | Purchase | Common Stock, $0.0001 par value per share | 1M | $14.50 | $15M | | 04/16/2020 |
| 02/24/2020 | Sio Gene Therapies Inc. | AXON | Purchase | Common Shares, par value $0.00001 per share | 5.3M | $3.75 | $20M | | 02/24/2020 |
| 12/27/2019 | Urovant Sciences Ltd. | UROV | Sale | Common Shares, par value $0.000037453 per share | 22.9M | $0.00 | $0 | See Footnote | 12/27/2019 |
| 12/27/2019 | Myovant Sciences Ltd. | MYOV | Sale | Common Shares, par value $0.000017727 per share | 45M | $0.00 | $0 | See Footnote | 12/27/2019 |
| 12/18/2019 | Immunovant, Inc. | IMVT | Other (acquisition) | Common Stock, $0.0001 par value per share | 36.9M | $10.00 | $369.2M | | 12/18/2019 |
| 12/18/2019 | Immunovant, Inc. | IMVT | Other (acquisition) | Series A Preferred Stock, $0.0001 par value per share | 10k | $10.00 | $100k | | 12/18/2019 |
| 12/17/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 75k | $15.94 | $1.2M | | 12/16/2019 |
| 12/16/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 131.5k | $14.97 | $2M | | 12/16/2019 |
| 12/16/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 38.5k | $15.68 | $603k | | 12/16/2019 |
| 12/04/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 72.5k | $17.04 | $1.2M | | 12/02/2019 |
| 12/04/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 2.5k | $17.56 | $44.4k | | 12/02/2019 |
| 12/02/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 113.7k | $18.21 | $2.1M | | 12/02/2019 |
| 12/02/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 65.5k | $18.85 | $1.2M | | 12/02/2019 |
| 11/25/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 3.5M | $15.00 | $52.5M | | 11/25/2019 |
| 11/21/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 103.6k | $11.80 | $1.2M | | 11/20/2019 |
| 11/21/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 18.3k | $12.38 | $226.5k | | 11/20/2019 |
| 11/20/2019 | Myovant Sciences Ltd. | MYOV | Purchase | Common Shares, par value $0.000017727 per share | 121.9k | $12.90 | $1.6M | | 11/20/2019 |
| 06/19/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 5k | $8.17 | $40.5k | | 06/17/2019 |
| 06/18/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.7k | $8.21 | $55.1k | | 06/17/2019 |
| 06/17/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.5k | $8.53 | $55.8k | | 06/17/2019 |
| 06/14/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.1k | $7.91 | $56.5k | | 06/12/2019 |
| 06/13/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.4k | $7.95 | $58.5k | | 06/12/2019 |
| 06/12/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.5k | $8.30 | $62.2k | | 06/12/2019 |
| 06/11/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.2k | $8.58 | $61.7k | | 06/07/2019 |
| 06/10/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 7.5k | $8.35 | $62.6k | | 06/07/2019 |
| 06/07/2019 | Urovant Sciences Ltd. | UROV | Purchase | Common Shares, par value $0.000037453 per share | 6.6k | $7.97 | $53k | | 06/07/2019 |
|